Year: 2019
Type: review
Abstract: Cancer cells activate stress-response mechanisms to adapt themselves to a variety of stressful conditions. Among these protective mechanisms, those controlled by the stress-induced nuclear protein 1 (NUPR1) belong to the most conserved ones. NUPR1 is an 82-residue-long, monomeric, basic and intrinsically disordered protein (IDP), which was found to be invariably overexpressed in some, if not all, cancer tissues. Remarkably, we and others have previously showed that genetic inactivation of the Nupr1 gene antagonizes the growth of pancreatic cancer as well as several other tumors. With the use of a multidisciplinary strategy by combining biophysical, biochemical, bioinformatic, and biological approaches, a trifluoperazine-derived compound, named ZZW-115, has been identified as an inhibitor of the NUPR1 functions. The anticancer activity of the ZZW-115 was first validated on a large panel of cancer cells. Furthermore, ZZW-115 produced a dose-dependent tumor regression of the tumor size in xenografted mice. Mechanistically, we have demonstrated that NUPR1 binds to several importins. Because ZZW-115 binds NUPR1 through the region around the amino acid Thr68, which is located into the nuclear location signal (NLS) region of the protein, we demonstrated that treatment with ZZW-115 inhibits completely the translocation of NUPR1 from the cytoplasm to the nucleus by competing with importins.
Source: Cells
DOI: 10.3390/cells8111453
Institutions: Centre National de la Recherche Scientifique, Inserm, Aix-Marseille Université, Centre de Recherche en Cancérologie de Marseille, Institut Paoli-Calmettes, Chongqing University, Centre Interdisciplinaire de Nanoscience de Marseille, Consejo Superior de Investigaciones Científicas, Universidad de Zaragoza, Fundacion Agencia Aragonesa para la Investigacion y el Desarrollo, Centro de Investigación Biomédica en Red, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Instituto de Investigación Sanitaria Aragón, Instituto de Biocomputación y Física de Sistemas Complejos, Instituto Aragonés de Ciencias de la Salud, Medical College of Wisconsin, University of Calabria, Universitat de Miguel Hernández d'Elx
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $1,824
Funders: Institut National de la Santé et de la Recherche Médicale, National Natural Science Foundation of China, Ministerio de Economía y Competitividad, Fondation ARC pour la Recherche sur le Cancer, Ligue Contre le Cancer, Fondation de France, China Scholarship Council, Institut National Du Cancer, Instituto de Salud Carlos III, National Cancer Institute, National Institute of Diabetes and Digestive and Kidney Diseases
Awards: Novel Experimental Therapeutics for Pancreatic Cancer, G3249978467, 新型Bola双靶向抑制剂的合成及抗肿瘤活性研究, Epigenomic Regulation in Pancreatic Cell Growth, EFECTO DE UNA DIETA HIPOCALORICA CON PATRON MEDITERRANEO SOBRE LA EXPRESIÓN GENICA EN CELULAS HUMANAS SANGUINEAS DE PACIENTES OBESOS, Análisis de las interacciones proteínas/metabolitos en plasma mediante calorimetría: aplicación como método diagnóstico rápido y no invasivo para detección precoz y seguimiento de patologías tumorales digestivas (DIGCal), G6374627064, G7109722980, G812023452
OpenAlex ID: W2982945619
